-->

Sid Martin Biotech Incubator

Roger BlevinsDr. Roger D. Blevins, PharmD

Past President, CEO of Medco Research and Xsira Pharmaceutical, Inc. 

Dr. Blevins is former CEO of Medco Research, Inc. (formerly NYSE:MRE), credited with the successful development of adenosine, both as an anti-arrhythmic agent (Adenocard® - FDA approved in 1989) and as an adjunct to cardiac imaging (Adenoscan® - FDA approved in 1995). More recently, Dr. Blevins was founding CEO of Xsira Pharmaceuticals, Inc. (formerly Norak Biosciences, Inc.), a private, venture-backed biotechnology company founded in 2000.